| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.50▼ | 1.49▲ | 1.48▲ | 1.48▲ | 1.40▲ |
| MA10 | 1.49▲ | 1.45▲ | 1.44▲ | 1.55▼ | 1.58▼ |
| MA20 | 1.44▲ | 1.47▲ | 1.49▲ | 1.54▼ | 1.85▼ |
| MA50 | 1.52▼ | 1.61▼ | 1.80▼ | 1.70▼ | 1.18▲ |
| MA100 | 1.63▼ | 1.76▼ | 1.64▼ | 1.91▼ | N/A |
| MA200 | 2.00▼ | 1.87▼ | 1.95▼ | 1.31▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.015▲ | 0.022▲ | 0.018▲ | -0.011▼ | N/A |
| RSI | 55.535▲ | 46.895▼ | 44.348▼ | 46.894▼ | N/A |
| STOCH | 99.242▲ | 89.909▲ | 75.728 | 14.027▼ | 11.537▼ |
| WILL %R | 0.000▲ | 0.000▲ | -7.407▲ | -84.337▼ | -84.337▼ |
| CCI | 64.368 | 92.328 | 61.970 | -44.037 | -68.143 |
|
Tuesday, November 17, 2020 08:21 AM
Active biotech and pharma companies in the markets this week include CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), Amarin Corporation plc (NASDAQ: AMRN), Alterity Therapeutics (NASDAQ: ATHE ...
|
|
Tuesday, November 17, 2020 12:30 AM
With the increasing prevalence of brain cancer, rising aging population, and growing incidences of cancer via chemical ...
|
|
Monday, November 16, 2020 03:44 PM
Shares of Alterity Therapeutics Ltd (NASDAQ: ATHE) gap-opened Monday's session higher and are sustaining the gains. What Happened: The Australian biopharma said the U.S. Patent and Trademark ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 03/12/20 | 1.45 | 1.62 | 1.42 | 1.48 | 651,000 |
| 02/12/20 | 1.38 | 1.49 | 1.36 | 1.44 | 354,200 |
| 01/12/20 | 1.46 | 1.47 | 1.37 | 1.40 | 645,800 |
| 30/11/20 | 1.56 | 1.56 | 1.48 | 1.52 | 414,400 |
| 27/11/20 | 1.55 | 1.59 | 1.53 | 1.55 | 196,500 |
| 25/11/20 | 1.53 | 1.60 | 1.52 | 1.55 | 562,900 |
| 24/11/20 | 1.57 | 1.64 | 1.49 | 1.57 | 1,085,800 |
| 23/11/20 | 1.65 | 1.71 | 1.61 | 1.64 | 926,500 |
| 20/11/20 | 1.68 | 1.68 | 1.56 | 1.60 | 1,012,300 |
| 19/11/20 | 1.76 | 1.77 | 1.70 | 1.77 | 1,453,044 |
|
|
||||
|
|
||||
|
|